The glucocorticoid receptor antagonist mifepristone reduces ethanol intake in rats under limited access conditions

Psychoneuroendocrinology
Heather N Koenig, M Foster Olive

Abstract

There is a substantial amount of evidence indicating control over ethanol intake by steroid hormones, particularly adrenal glucocorticoids. Thus far, however, studies employing pharmacological methods have failed to find effects of glucocorticoid receptor blockade on voluntary ethanol consumption. Since length of ethanol access period can influence ethanol consumption levels as well as potential pharmacological effects in such studies, the present study was conducted to determine the effects of acute administration of the glucocorticoid receptor (GR) antagonist mifepristone on voluntary ethanol intake under limited access conditions. Rats were fluid restricted and given concurrent access to 10% ethanol and water in a two-bottle choice paradigm for 1 h/day, 5 days a week. Both fluids were available ad libitum during the remaining 2 days per week. Administration of mifepristone (1, 5 and 20 mg/kg i.p.) immediately prior to the limited access two-bottle access period dose-dependently suppressed ethanol intake (maximum 40% at 20 mg/kg). The mineralcorticoid receptor (MR) antagonist spironolactone (10, 25 and 50 mg/kg i.p.) was without effect on ethanol intake, and neither compound had an effect on water intake. These data confirm a...Continue Reading

References

Jun 1, 1975·Journal of Steroid Biochemistry·B S McEwenE R de Kloet
May 1, 1992·Trends in Pharmacological Sciences·H H Samson, R A Harris
May 1, 1992·Trends in Pharmacological Sciences·G F Koob
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·A HärfstrandH Steinbusch
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M AronssonJ A Gustafsson
Sep 23, 1966·Annals of the New York Academy of Sciences·J H Mendelson, N K Mello
Jan 1, 1984·Alcohol·F A HollowayJ A Devenport
Jun 1, 1994·Human Reproduction·O HeikinheimoP Lähteenmäki
Jan 1, 1996·Pharmacology & Therapeutics·M K Agarwai
Mar 26, 1998·Alcoholism, Clinical and Experimental Research·G F KoobF Weiss
Jan 12, 1999·Neuroscience and Biobehavioral Reviews·J HallerM R Kruk
Jul 25, 2000·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·J R WolfeB A McMillen
Nov 25, 2000·Trends in Endocrinology and Metabolism : TEM·R J Borski
May 31, 2002·Journal of Medicinal Chemistry·Bradley P MorganJon Bordner

❮ Previous
Next ❯

Citations

Oct 12, 2012·Cognitive, Affective & Behavioral Neuroscience·Chester A ThaiJohn G Howland
Feb 5, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Emily G LoweryTodd E Thiele
Nov 4, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jeffrey A SimmsSelena E Bartlett
Feb 16, 2012·The Journal of Pharmacology and Experimental Therapeutics·Raúl PastorTamara J Phillips
Jun 1, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Leandro F VendruscoloGeorge F Koob
Feb 11, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lynn M OswaldGary S Wand
Sep 21, 2010·Neurobiology of Learning and Memory·Ming ZhouHarm J Krugers
May 25, 2015·Alcohol·Scott EdwardsLeandro F Vendruscolo
Aug 25, 2007·Biological Psychiatry·Lucianne GroeninkBerend Olivier
Oct 16, 2008·Addiction Biology·Magdalena Uhart, Gary S Wand
Mar 27, 2013·Alcoholism, Clinical and Experimental Research·Lynda Sharrett-FieldMark A Prendergast
Nov 20, 2010·Alcoholism, Clinical and Experimental Research·A K RoseH J Little
Sep 20, 2006·Progress in Neurobiology·Norman PecoraroSusan F Akana
Aug 26, 2006·Pharmacology, Biochemistry, and Behavior·Mark A Prendergast, Hilary J Little
Feb 7, 2006·Biological Psychiatry·Haim Einat, Husseini K Manji
Feb 6, 2007·Psychoneuroendocrinology·Eva MikicsJózsef Haller
Jun 30, 2015·The Journal of Clinical Investigation·Leandro F VendruscoloBarbara J Mason
Jun 3, 2016·Integrative and Comparative Biology·Ben DantzerFreya van Kesteren
Aug 17, 2016·International Journal of Molecular Sciences·Bin QiuTiebing Liang
Jul 19, 2018·Expert Opinion on Investigational Drugs·Leigh C Walker, Andrew J Lawrence
Oct 31, 2006·Psychopharmacology·Nandakumar NagarajaB V Venkataraman
Apr 6, 2013·Pflügers Archiv : European journal of physiology·Lynda Sharrett-FieldMark A Prendergast
Sep 3, 2020·The Journal of Pharmacology and Experimental Therapeutics·Vanessa A JimenezKathleen A Grant
Apr 23, 2017·Neuropharmacology·Howard C Becker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.